FDA Drug recall D-0283-2022
Methylcobalamin 12mg/ml injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409
- FDA Drug
- Class II
- terminated
- Published 2021-12-22
On 2021-12-22 the FDA classified a Class II recall of Methylcobalamin 12mg/ml injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409 by Valgene, citing lack of Processing Controls.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0283-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-12-03 |
| Published | 2021-12-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Valgene |
| Distribution | MD |
Product
Methylcobalamin 12mg/ml injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409
Reason
Lack of Processing Controls
Identifiers
| code_info | Lot #: 188008, BUD 03/19/2022 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0283-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.